The Technical Advisory Group of the World Heath Organization (WHO) will meet on October 26 to consider Emergency Use Listing (EUL) for Covaxin, the Covid-19 vaccine of Bharat Biotech.
“The technical advisory group will meet on Oct 26 to consider EUL for Covaxin. WHO has been working closely with Bharat Biotech, to complete the dossier,” Soumya Swaminathan, Chief Scientist, WHO, said in a social media post. “Our goal is to have a broad portfolio of vaccines approved for emergency use and to expand access to populations everywhere,” she added.
Also read: Covaxin review
In response, Suchitra Ella, Joint Managing Director, Bharat Biotech said, “We believe our efforts to make Covaxin achieve EUL will be soon realised with regulatory compliances, enable further access of pandemic vaccines to the world.”
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.